MS Drug May Lead to Seizures

In a report from Reuters, the FDA has issued a warning concerning an MS drug that may lead to seizures. The drug, Amprya, manufactured by Biogen Inc. and Acorda Therapeutics Inc., is designed to improve symptoms to make walking easier. 

However, it is also found to increase the risk of seizures in patients with multiple sclerosis. As a result, the manufacturer has updated their label to warn patients. It also warns that individuals taking the drug should have their kidney function checked before taking it and then on a yearly basis once they have begun treatment with the drug. 

Drug Labeling Requirements 

The U.S. Food and Drug Administration (FDA) regulates drugs to make sure they comply with appropriate standards, including requirements pertaining to labels. This means that the label must clearly and accurately state what the drug is intended for. 

In addition, if there is health risks to consumers, warnings must also be provided on the label. Missing or misleading information could lead the FDA to issue an alert for the drug. In some cases, it may even result in the drug being pulled. 

Contacting a New York Dangerous Drug Lawyer 

Drugs that are dangerous and lead to serious or fatal injuries may warrant filing a claim. To learn if you are eligible to seek compensation, contact a lawyer who handles these types of cases. 

A dangerous drug lawyer at Gacovino Lake & Associates may be able to help. We have formed a dedicated network of dangerous drug attorneys that serve clients nationwide. Our New York office serves residents of the five boroughs with their auto accident, medical malpractice, defective drug, premises liability, and Workers’ Compensation claims. For experienced help with your dangerous drug claim, contact us today – 1-800-246-4878.

Related Posts